Actionable news
0
All posts from Actionable news
Actionable news in WBMD: WebMD Health Corp,

SunTrust Upgrades WebMD To Buy Following Q1 Results

SunTrust Robinson Humphrey analyst Sandy Draper, responding to WebMD Health Corp. WBMD 1.26%'s first quarter earnings report, upgraded the stock from Neutral to Buy Thursday morning.

"We see the positive biopharma market growth as a sustainable tailwind to drive double-digit top line and high teens EBITDA growth for 3-5 years," Draper said.

"WebMD has demonstrated that it is a demand-driven model with ad-revenue in 1Q16 growing at 15.7% y/y, which far outpaced the 4% growth in page-view traffic observed over the same time frame. We reason that the incremental benefit of additional page-view traffic is less important to drive revenue growth given WBMD ranks number one in unique visitors (about 50% more than nearest competitor), page views (2.5x nearest competitor) and time spent on the website by a wide margin," according to the SunTrust analyst.

Amid increased sales estimates, Draper boosted her price target on WebMD shares from $57 to $75.

Although volatile over the course of Thursday's session, the stock closed up a moderate 0.85 percent at $63.29 Thursday.

Draper's new price target represents potential upside of about 19 percent.

DateFirmActionFromTo
May 2016SunTrust Robinson HumphreyUpgradesNeutralBuy
May 2016Leerink SwannMaintainsOutperform
Apr 2016CitigroupInitiates Coverage onNeutral

© 2016 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.